4QL-17077-28009
1 vaccination
1 coded response
5 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 633 / MO
- Registered
- 2021-08-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-18
Dose 1 — Pfizer-BioNTech
-
2021-08-19
Registered in v-safe
-
2021-08-19
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-08-20
Survey response — days 1–6 daily, dose 1MedDRA: Cough — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, NauseaFree text: CoughMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-21
- 2021-08-22
- 2021-08-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-18 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release